Novartis AG (Switzerland) II-102
Ortho Biotech Products, L.P (USA) II-103
OSI Pharmaceuticals, Inc. (USA) II-103
Pfizer (USA) II-103
Sanofi-Aventis (France) II-104
Schering Plough Corporation (USA) II-105
Seattle Genetics, Inc. (USA) II-105
Takeda Pharmaceutical Company Limited (Japan) II-105
Wyeth (USA) II-106
7. Market Perspective II-107
Table 24: Global Recent Past, Current & Future Analysis for
Cancer Therapies by Type - Targeted Therapy, Chemotherapy,
Hormone Therapy, and Immunotherapy Markets Independently
Analyzed with Annual Sales Figures in US$ Billion for Years
2006 through 2015 (includes corresponding Graph/Chart) II-107
Table 25: Global Historic Review for Cancer Therapies by Type -
Targeted Therapy, Chemotherapy, Hormone Therapy, and
Immunotherapy Markets Independently Analyzed with Annual
Sales Figures in US$ Billion for Years 2000 through 2005
(includes corresponding Graph/Chart) II-107
Table 26: Global 10-Year Perspective for Cancer Therapies by
Type - Percentage Breakdown of Dollar Sales for Targeted
Therapy, Chemotherapy, Hormone Therapy, and Immunotherapy
for Years 2006, 2009 & 2015 (includes corresponding
Graph/Chart) II-108
III. COMPETITIVE LANDSCAPE
To order this report:
http://www.reportlinker.com/p0109886/World-Cancer-Therapies-Market.html
More market research reports here!
Nicolas Bombourg
Reportlinker
Ema
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |